Compounds > enrofloxacin
Page last updated: 2024-08-25

enrofloxacin and Bacterial Infections, Gram-Negative

enrofloxacin has been researched along with Bacterial Infections, Gram-Negative in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's2 (25.00)29.6817
2010's3 (37.50)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
de Oliveira, TF; de Queiróz, GA; Leal, CAG; Pimenta Leibowitz, M1
DI, GL; Jin, ZH; Kong, XH; Li, L; Zhao, XL1
Cardoso, IL; Estaiano de Rezende, RA; Ishikawa, MM; Lima Dallago, BS; Rantin, FT; Sampaio, FG; Soares, MP; Teixeira Duarte, MC1
Lu, L; Wang, H; Xu, L; Yang, X1
Fan, J; Li, L; Liu, S; Shan, Q; Wang, J; Zheng, G1
Buck, LT; Harapa, GM; Ramaglia, V; White, N1
Cavana, P; Farca, AM; Nebbia, P; Robino, P1
Batt, RM; Elwood, CM; Rutgers, HC; Simpson, KW; Stepien, RL1

Trials

1 trial(s) available for enrofloxacin and Bacterial Infections, Gram-Negative

ArticleYear
Phytobiotics blend as a dietary supplement for Nile tilapia health improvement.
    Fish & shellfish immunology, 2021, Volume: 114

    Topics: Aeromonas hydrophila; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Anti-Bacterial Agents; Cichlids; Diet; Dietary Supplements; Enrofloxacin; Fish Diseases; Gram-Negative Bacterial Infections; Lippia; Phytotherapy; Plant Oils; Thymus Plant

2021

Other Studies

7 other study(ies) available for enrofloxacin and Bacterial Infections, Gram-Negative

ArticleYear
Therapeutic efficacy of enrofloxacin in treatment of Francisella orientalis infections in juvenile Nile tilapia (Oreochromis niloticus L.).
    Journal of veterinary pharmacology and therapeutics, 2023, Volume: 46, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Cichlids; Enrofloxacin; Fish Diseases; Francisella; Gram-Negative Bacterial Infections; Oxytetracycline

2023
Molecular characteristics, pathogenicity and medication regimen of Aeromonas hydrophila isolated from common carp (Cyprinus carpio L.).
    The Journal of veterinary medical science, 2019, Dec-26, Volume: 81, Issue:12

    Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Aquaculture; Carps; Drug Resistance, Multiple; Enrofloxacin; Fish Diseases; Gram-Negative Bacterial Infections; Hemorrhagic Septicemia

2019
Integrated pharmacokinetics/pharmacodynamics parameters-based dosing guidelines of enrofloxacin in grass carp Ctenopharyngodon idella to minimize selection of drug resistance.
    BMC veterinary research, 2013, Jun-25, Volume: 9

    Topics: Aeromonas hydrophila; Animals; Anti-Bacterial Agents; Carps; Drug Resistance, Bacterial; Enrofloxacin; Fish Diseases; Fluoroquinolones; Gram-Negative Bacterial Infections; Lethal Dose 50; Practice Guidelines as Topic

2013
Comparative pharmacokinetics of enrofloxacin in healthy and Aeromonas hydrophila-infected crucian carp (Carassius auratus gibelio).
    Journal of veterinary pharmacology and therapeutics, 2017, Volume: 40, Issue:5

    Topics: Aeromonas hydrophila; Animals; Area Under Curve; Enrofloxacin; Fish Diseases; Fluoroquinolones; Goldfish; Gram-Negative Bacterial Infections

2017
Bacterial infection and tissue-specific Hsp72, -73 and -90 expression in western painted turtles.
    Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 2004, Volume: 138, Issue:2

    Topics: Animals; Brain; Chloramphenicol; Dermatitis; Enrofloxacin; Female; Fluoroquinolones; Gram-Negative Bacterial Infections; Heart; Heat-Shock Proteins; Heat-Shock Response; HSC70 Heat-Shock Proteins; HSP70 Heat-Shock Proteins; HSP72 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Liver; Male; Muscle, Skeletal; Myocardium; Organ Specificity; Quinolones; Sepsis; Turtles

2004
In vitro antimicrobial activity of marbofloxacin and enrofloxacin against bacterial strains isolated from companion animals.
    Schweizer Archiv fur Tierheilkunde, 2007, Volume: 149, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Colony Count, Microbial; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Enrofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Quinolones; Treatment Outcome

2007
Enrofloxacin treatment of gram-negative infections.
    The Veterinary record, 1994, Oct-08, Volume: 135, Issue:15

    Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Resistance, Microbial; Enrofloxacin; Escherichia coli Infections; Fluoroquinolones; Gram-Negative Bacterial Infections; Pseudomonas Infections; Quinolones; Salmonella Infections, Animal

1994